These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6442042)

  • 1. [Rate of elimination of human high-density lipoproteins after their intravenous administration in rabbits by the loss of alpha- cholesterol and apoprotein A-1].
    Polikarpova LI; Teriukova NP; Kalashnikova NM; Oleĭnik IA; Klimov AN
    Vopr Med Khim; 1984; 30(6):98-101. PubMed ID: 6442042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The rate of elimination of homologous and heterologous native and modified high density lipoproteins from rabbit plasma after their intravenous administration].
    Polikarpova LI; Ioffe DV; Teriukova NP; Kalashnikova NM; Oleĭnik IA
    Vopr Med Khim; 1986; 32(4):63-72. PubMed ID: 3094247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of hypercholesterolemia in the rabbit with semisynthetic diets. Changes in the composition of high density lipoproteins].
    Sánchez-Muniz FJ; Terpstra AH
    Rev Esp Fisiol; 1988 Mar; 44(1):45-9. PubMed ID: 3140314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis].
    Scarazatti E; Garavaglia G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):15-21. PubMed ID: 3977994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The rate of elimination of heterologous native and modified high-density lipoproteins from rabbit blood plasma after their intravenous administration].
    Polikarpova LI; Ioffe DV; Teriukova NP; Kalashnikova NM; Lozovskiĭ VT
    Vopr Med Khim; 1984; 30(2):91-5. PubMed ID: 6331002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoprotein A-1 in high-density lipoprotein subfractions and lecithin-cholesterol-acyltransferase activity in hyperalphacholesterinemia].
    Perova NV; Metel'skaia VA; Ozerova IN; Gadzhalova SI; Chernysheva NP
    Vopr Med Khim; 1980; 26(5):688-94. PubMed ID: 7423887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antioxidant activity of high density lipoproteins in vivo].
    Klimov AN; Gurevich VS; Nikiforova AA; Shatilina LV; Kuz'min AA; Plavinskiĭ SL; Teriukova NP
    Biull Eksp Biol Med; 1992 Jul; 114(7):40-2. PubMed ID: 1421304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catabolism of native and modified high-density lipoproteins in rabbits].
    Klimov AN; Teriukova NP; Polikarpova LI; Ioffe DV; Kalashnikova NM
    Vopr Med Khim; 1987; 33(2):106-11. PubMed ID: 3604131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
    Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
    Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute influence of smoking on plasma lipoproteins.
    Gnasso A; Haberbosch W; Schettler G; Schmitz G; Augustin J
    Klin Wochenschr; 1984; 62 Suppl 2():36-42. PubMed ID: 6482326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological assay of apolipoprotein A-I].
    Ayrault-Jarrier M; Bobilewicz D; Pastier D; Beucler I; Polonovski J
    Ann Biol Clin (Paris); 1982; 40(3):187-94. PubMed ID: 6814305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemiluminescence of apo-B-lipoproteins in experimental hypercholesterolemia of rabbits].
    Lopukhin IuM; Molodenkov MN; Vladimirov IuA; Sergienko VI; Klebanov GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):101-2. PubMed ID: 7082788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro.
    Gordon V; Innerarity TL; Mahley RW
    J Biol Chem; 1983 May; 258(10):6202-12. PubMed ID: 6343371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P; Celis H; Desager JP; Fagard R
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of HDL cholesterol/apolipoprotein A-I ratio].
    Okamoto Y; Tsujii H; Sakamoto S; Nakano H; Haga Y; Nakai S; Tamura M
    Rinsho Byori; 1990 Oct; 38(10):1193-7. PubMed ID: 2124636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acceptance of cholesterol by high density lipoproteins in people with dys-alpha-lipoproteinemia and the possible role of apoprotein E in this process].
    Kozhevnikova KA; Petrova-Maslakova LG; Parfenova NS; Belova EV; Triufanov VF; Noskin VA; Vavrin RZ
    Vopr Med Khim; 1989; 35(4):43-8. PubMed ID: 2815679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.